The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
8,552
Sort by:
Calming and Sleeping in Taiwan
US$ 990.00
Calming and sleeping remained insignificant in 2011, as calming and sleeping products were only available on prescription in Taiwan during the review period. Euromonitor International's Calming and Sleeping in Taiwan report ... . Why buy this report? Get a detailed picture of the Calming and Sleeping market; Pinpoint growth sectors and identify factors driving change ...
April 2012
17 pages
2012 Global Drugs of Abuse Testing Market Outlook: Growth Opportunities and Strategies
US$ 6,000.00
... a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. "Drugs of Abuse Testing Market: US, Europe, Japan" is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging ...
April 2012
311 pages
Smoking Cessation Drugs: World Market Prospects 2012-2022
US$ 2,633.00
... . R&D is promising. New formulations and generics will be important too. Innovations in drug delivery and rising demand in developing countries will also stimulate ... , 29 charts and three research interviews. Eight ways Smoking Cessation Drugs: World Market Prospects 2012-2022 helps you In particular, our ...
April 2012
116 pages
Emergency Contraception in Belarus
US$ 990.00
... be used under medical supervision. Most of the hormonal contraceptive medicines in Belarus are Rx products. Euromonitor International's Emergency Contraception in Belarus report offers a comprehensive guide to the size ... data. Why buy this report? Get a detailed picture of the Emergency Contraception market; Pinpoint growth sectors and identify factors driving change ...
April 2012
19 pages
NRT Smoking Cessation Aids in Belarus
US$ 990.00
... to lower the smoking rate. Heart disease accounts for some 88% of deaths from smoking-related illnesses in Belarus. Other... Euromonitor International's NRT Smoking Cessation Aids in Belarus report offers a comprehensive ... data. Why buy this report? Get a detailed picture of the NRT Smoking Cessation Aids market; Pinpoint growth sectors and identify factors driving change ...
April 2012
24 pages
Global Drugs Retail Industry 2012 - 2017: Trend, Profit, and Forecast Analysis
US$ 1,980.00
... the Global Drug Retail market and presents its findings in “Global Retail Drug Industry 2012-2017: Trend, Profit, and Forecast Analysis.” The drug industry consists of pharmacies and drug ... (Q1 2012 – Q4 2012) for global drugs retail industry analysis Gross and net profit trends in the global drugs retail industry analysis Cost structure trend in the global as well as regional global drugs retail industry ...
April 2012
RNA Interference (RNAi): Market Research Report
US$ 4,800.00
This report analyzes the worldwide markets for RNA Interference (RNAi) in US$ Million by the following Application Areas: Drug Discovery and Target ... , Inc., Exiqon A/S, Genesis Research & Development Corporation Limited, Halo-Bio RNAi Therapeutics, Inc., Marina Biotech, Inc., OPKO Health, Inc., Polyplus- ...
March 2012
792 pages
The World Anesthesia Drug Market (General, Local, Adjunctive)
US$ 3,995.00
This Kalorama Information report – The World Anesthesia Drug Market - focuses on three primary segments of anesthesia: General Anesthesia Local Anesthesia Adjunctive Therapies ... several issues and trends that are impacting the anesthesia drug market. Many of the issues are centered on safety issues, which ...
March 2012
190 pages
Calming and Sleeping in Bolivia
US$ 990.00
During the review period, consumer lifestyles in Bolivia became busier and more stressful due to economic development, longer ... complaints, these trends continued to drive demand for calming and sleeping products in... Euromonitor International's Calming and Sleeping in Bolivia report offers a comprehensive guide to the size ...
March 2012
21 pages
World Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)
US$ 3,995.00
This Kalorama Information report, The Worldwide Market for Prescription Dermatological Drugs represents the eighth time that Kalorama has detailed the various ... the market for treatments in the future. It is a time of change for this market sector, with OTC product launches, rising skin cancer incidence and ...
February 2012
300 pages
Drug Industry in the United States - Porter’s Five Forces Strategy Analysis
US$ 175.00
... falling, leading to layoffs and cuts in research budgets. While the US drug industry is hardly in a full-blown crisis, however, layoffs are occurring ... taken once a week instead of daily. Aruvian's R'search analyzes the United States Drug Industry in the Michael Porter’s Five Forces Analysis. It uses concepts ...
February 2012
12 pages
Outsourcing in Drug Development: The Contract Research (Clinical Trial ) Market
US$ 3,995.00
... can expect growing demand for their services. The demand for new drugs remains unabated, but the cost and need to bring those drugs to ... (AMC), Contract Research Organizations and Others. Main Drivers for Outsourcing in Drug Development How CROs are Meeting the Challenge of Patient Recruitment Discussion ...
January 2012
235 pages
Antithrombotic/Anticoagulant Drugs: World Market 2012-2022
US$ 2,635.00
... presentations. You will find answers in our work. Revenue forecasts, market shares, developmental trends, discussions and interviews In the report you ... charts and four research interviews. Advantages of Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 for your work In particular, this study ...
January 2012
120 pages
Generic Drug Market in Canada
US$ 1,000.00
Canada is one of the world’s largest pharmaceutical markets, even though it has a low share of only 3% in global pharma industry. In 2010, generics accounted for more than 57% prescriptions and around...
November 2011
65 pages
Multiple Sclerosis Treatment: World Drug Market 2012-2022
US$ 2,635.00
... tables and charts and three research interviews. Advantages of Multiple Sclerosis Treatment: World Drug Market 2012-2022 for your work Our ... , viewing sales growth Discover revenue forecasts to 2022 for leading MS drugs, assessing commercial potential Assess leading companies, discovering their activities ...
November 2011
116 pages
The UK Vitamin and Dietary Supplements Demand and Forecast
US$ 630.00
Executive summary The UK is one of the developed countries of Western Europe and has a well-formed nutrients & supplements market in the world. The industry has been registering growth primarily...
September 2011
36 pages
Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
... information and analysis of the leading players in the Global Cardiovascular Drug Market. The report provides a worldwide strategic overview of the pharmaceutical ... , demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key ...
September 2011
1353 pages
Global CNS Drug Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
... product segments: ethical, OTC, generics. Sales forecast for major drug categories. Sales forecasts by geographical region: North America, Europe, Japan, ... , capabilities, goals and strategies of the leading players in the global CNS drug market. To help current suppliers realistically assess their financial ...
September 2011
1353 pages
Global Oncology Drug Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
... information and analysis of the leading players in the Global Oncology Drug Market. The report provides a worldwide strategic overview of the pharmaceutical ... economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key ...
September 2011
1353 pages
Emergency Contraception in Ukraine
US$ 990.00
... simply unable to afford emergency contraception, particularly as unregulated prices resulted in a wide variance in price across chemists/pharmacies. Euromonitor International's Emergency Contraception in Ukraine report offers a comprehensive ... data. Why buy this report? Get a detailed picture of the Emergency Contraception market; Pinpoint growth sectors and identify factors driving change ...
September 2011
19 pages
Booming Generics Drug Market in India
US$ 1,000.00
Single User PDF Format: US$ 1,000.00
Multi-User License: US$ 1,800.00
Hard Copy: US$ 1,200.00
CD-ROM: US$ 1,200.00 The world has witnessed a sharp increase in the demand for cost-effec...
August 2011
60 pages
U.S. Hyaluronic Acid Viscosupplementation Physician Survey 2011
US$ 7,495.00
Over 100 orthopedic specialists were surveyed regarding their perceptions and usage of hyaluronic acid viscosupplementation during the 2011 American Academy of Orthopaedic Surgeons (AAOS) conference. This survey report compares usage patters and perceptions of orthopedic specialists regarding hyaluronic acid ...
July 2011
80 pages
International Hyaluronic Acid Viscosupplementation Physician Survey 2011
US$ 11,495.00
Over 100 orthopedic specialists were surveyed regarding their perceptions and usage of hyaluronic acid viscosupplementation during the 2011 American Academy of Orthopaedic Surgeons (AAOS) conference. This survey report compares usage patters and perceptions of orthopedic specialists regarding hyaluronic acid ...
July 2011
91 pages
Generic Drugs in Consumer Health Global Overview 2011
US$ 2,000.00
... are slowly becoming an ally in a strategy to boost sales. Euromonitor International’s Generic Drugs in Consumer Health Global Overview 2011 global briefing examines the ... data. Why buy this report? Get a detailed picture of the Consumer Health market; Pinpoint growth sectors and identify factors driving ...
July 2011
50 pages
Global Obesity Drug Market Analysis
US$ 1,000.00
Single User PDF Format: US$ 1,000.00 Multi-User License: US$ 1,500.00 Hard Copy: US$ 1,100.00 CD-ROM: US$ 1,100.00 The obesity epidemic has been disseminating among developed countries as well as low...
June 2011
85 pages
Drug Combinations: New Rules, New Opportunities
US$ 895.00
Single symptom. Single illness. Single drug.
For years, drug therapy has been built on that basic equation. Yet as genomic biology sheds light on the astonishing intricacy of disease patholo...
May 2011
48 pages
Vitamins and Dietary Supplements in Indonesia
US$ 900.00
Vitamins and dietary supplements continued to record healthy double-digit current retail value growth in 2010, with sales being boosted by the increasing popularity of preventive medicine, especially...
May 2011
44 pages
Acute Coronary Syndrome (ACS) Drug Market Prospects 2011-2021
US$ 2,325.00
... and a research interview (shown in the accompanying lists). Acute Coronary Syndrome (ACS) Drug Market Prospects 2011-2021 shows you revenue ... technologies in development, assessing potential among the R&D product candidates for ACS You will investigate competition and opportunities influencing the industry ...
May 2011
132 pages
Global Alzheimer Prevalence and Drugs Demand
US$ 630.00
EXECUTIVE SUMMARY
The report on “Global Alzheimer Prevalence and Drugs Demand” includes the overall market for the treatment of Alzheimer, performance of drugs by sales and market share. In...
April 2011
37 pages
Production, Market and Benchmarking of Synthetic Vitamin E in China
US$ 14,897.00
... vitamin E producers’ competitiveness in China, CCM did production benchmarking analysis of three major vitamin E producers in China. What is the detailed ... in China in 2011? This report combines CCM’s expertise in vitamin E market research. Aspects as follows can be expected: Production situation ...
April 2011
57 pages
Bangladesh Vitamins & Minerals Market Report & Forecasts
US$ 750.00
IMARC’s new report “Bangladesh Vitamins & Minerals Market Report & Forecasts” provides an analytical and statistical insight into the Bangladesh vitamins and minerals market. The report provides both...
April 2011
147 pages
Competitor Analysis: Emerging Diabetes Drugs
US$ 870.00
Product description The present Competitive Intelligence Report about Emerging Diabetes Drugs provides a competitor evaluation in the field of novel molecules against a series of novel targets being developed for treatment of type 1 or 2 diabetes as of April 2011. Pharmacologic approaches include SGLT ...
April 2011
104 pages
World Diabetes Drug Market 2011-2021
US$ 2,325.00
... , Levemir, Actraphane HM, Actos, Avandia, Avandamet, Januvia and Byetta will perform to 2021. We also discuss insulin delivery technologies. Our review of research and ... for you to stay ahead in this industry and market. World Diabetes Drug Market 2011-2021 shows you revenue trends, opportunities and ...
March 2011
224 pages
Analgesics - Hong Kong, China
US$ 900.00
Analgesics continued to see steady growth in value sales in 2010, of 4%, which was in line with the review period average. Growth was driven by a strong performance by topical analgesics.
Eur...
March 2011
25 pages
Calming and Sleeping - Czech Republic
US$ 900.00
Calming and sleeping recorded a healthy review period current retail value CAGR of 3%. Consumption in this area is being fuelled by the fact that the increasingly hectic and stressful pace of modern l...
March 2011
24 pages